Actively Recruiting
Conjunctival Transpositional Surgery for Primary Pterygium
Led by Zahedan University of Medical Sciences · Updated on 2026-01-15
70
Participants Needed
1
Research Sites
84 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective single-arm interventional study evaluates the recurrence rate and functional outcomes following conjunctival transpositional pterygium surgery without bare sclera formation. The technique involves mobilization and transposition of the pterygium tissue while preserving Tenon's layer and avoiding adjunctive therapies.
CONDITIONS
Official Title
Conjunctival Transpositional Surgery for Primary Pterygium
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Primary pterygium involving the cornea
- Ability to provide informed consent
You will not qualify if you...
- Recurrent pterygium
- Previous ocular surface surgery
- Active ocular infection or inflammation
- Severe ocular surface disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Alzahra Eye Hospital, Zahedan University of Medical Sciences
Zahedan, Sistan and Balochistan, Iran
Actively Recruiting
Research Team
M
Mohammed Arish, MD, FRCS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here